Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Relay Therapeutics (RLAY) Asset Utilization Ratio (2021 - 2025)

Historic Asset Utilization Ratio for Relay Therapeutics (RLAY) over the last 6 years, with Q3 2025 value amounting to 0.01.

  • Relay Therapeutics' Asset Utilization Ratio rose 164.8% to 0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01, marking a year-over-year increase of 164.8%. This contributed to the annual value of 0.01 for FY2024, which is 5560.97% down from last year.
  • As of Q3 2025, Relay Therapeutics' Asset Utilization Ratio stood at 0.01, which was up 164.8% from 0.01 recorded in Q2 2025.
  • Relay Therapeutics' 5-year Asset Utilization Ratio high stood at 0.04 for Q2 2024, and its period low was 0.0 during Q2 2023.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.0 (2021), whereas its average is 0.01.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first soared by 1758274.39% in 2021, then plummeted by 7807.1% in 2025.
  • Quarter analysis of 5 years shows Relay Therapeutics' Asset Utilization Ratio stood at 0.0 in 2021, then plummeted by 66.23% to 0.0 in 2022, then surged by 2296.6% to 0.03 in 2023, then plummeted by 61.93% to 0.01 in 2024, then grew by 7.53% to 0.01 in 2025.
  • Its Asset Utilization Ratio was 0.01 in Q3 2025, compared to 0.01 in Q2 2025 and 0.01 in Q1 2025.